QTRX - Quanterix Corporation
NASDAQ
->
Healthcare
->
Medical Devices
Billerica,
United States
Type: Equity
QTRX price evolution
QTRX
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $49.61 | $47.89 | $177.03 | $203.91 |
| Short term investments | $249.85 | $256.64 | $146.9 | $126.45 |
| Net receivables | $31.78 | $29.28 | $25.41 | $24.08 |
| Inventory | $28.36 | $26.02 | $22.36 | $19.95 |
| Total current assets | $365.73 | $366.76 | $378.39 | $381.01 |
| Long term investments | ||||
| Property, plant & equipment | $35.6 | $35.24 | $36.18 | $37.38 |
| Goodwill & intangible assets | $4.98 | $5.34 | $6.03 | $6 |
| Total noncurrent assets | $45.56 | $44.99 | $46.62 | $48.03 |
| Total investments | $249.85 | $256.64 | $146.9 | $126.45 |
| Total assets | $411.29 | $411.75 | $425.01 | $429.04 |
| Current liabilities | ||||
| Accounts payable | $7.27 | $3.91 | $5.05 | $4.79 |
| Deferred revenue | $11.05 | $11.17 | $10.7 | $10.95 |
| Short long term debt | $4.52 | $4.37 | $4.24 | $4.09 |
| Total current liabilities | $37.54 | $32.24 | $38.46 | $35.15 |
| Long term debt | $35.05 | $36.08 | $37.22 | $38.31 |
| Total noncurrent liabilities | $37 | $38.07 | $39.63 | $40.54 |
| Total debt | $39.58 | $40.45 | $41.46 | $42.4 |
| Total liabilities | $74.54 | $70.31 | $78.08 | $75.69 |
| Shareholders' equity | ||||
| Retained earnings | -$454.04 | -$444.57 | -$434.5 | -$422.09 |
| Other shareholder equity | -$3.15 | -$3.04 | -$1.76 | -$3.21 |
| Total shareholder equity | $336.75 | $341.44 | $346.93 | $353.35 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $177.03 | $341.34 | $399.04 | $182.58 |
| Short term investments | $146.9 | |||
| Net receivables | $25.41 | $19.02 | $23.79 | $17.18 |
| Inventory | $22.36 | $16.79 | $22.19 | $14.86 |
| Total current assets | $378.39 | $381.4 | $448.95 | $219.6 |
| Long term investments | ||||
| Property, plant & equipment | $36.18 | $41.38 | $29.45 | $25.91 |
| Goodwill & intangible assets | $6.03 | $7.52 | $20.17 | $24.18 |
| Total noncurrent assets | $46.62 | $52.8 | $52.57 | $51.44 |
| Total investments | $146.9 | |||
| Total assets | $425.01 | $434.2 | $501.53 | $271.05 |
| Current liabilities | ||||
| Accounts payable | $5.05 | $3.84 | $9.21 | $6.8 |
| Deferred revenue | $10.7 | $10.06 | $7.46 | $6 |
| Short long term debt | $4.24 | $2.69 | $1.43 | $7.67 |
| Total current liabilities | $38.46 | $30.96 | $36.98 | $39.8 |
| Long term debt | $37.22 | $41.42 | $20.46 | $21.89 |
| Total noncurrent liabilities | $39.63 | $44.3 | $23.6 | $25.12 |
| Total debt | $41.46 | $44.1 | $20.46 | $29.56 |
| Total liabilities | $78.08 | $75.26 | $60.58 | $64.92 |
| Shareholders' equity | ||||
| Retained earnings | -$434.5 | -$402.16 | -$305.46 | -$247.77 |
| Other shareholder equity | -$1.76 | -$2.62 | $0.44 | $2.43 |
| Total shareholder equity | $346.93 | $358.94 | $440.95 | $206.13 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $34.38 | $32.07 | $31.55 | $31.33 |
| Cost of revenue | $14.32 | $12.44 | $14.75 | $13.55 |
| Gross Profit | $20.06 | $19.63 | $16.8 | $17.78 |
| Operating activities | ||||
| Research & development | $8.1 | $6.67 | $6.99 | $7.2 |
| Selling, general & administrative | $24.14 | $25.99 | $24.17 | $23.59 |
| Total operating expenses | $33.17 | $33.59 | $33.75 | $31.55 |
| Operating income | -$13.11 | -$13.97 | -$16.95 | -$13.77 |
| Income from continuing operations | ||||
| EBIT | -$9.44 | -$9.81 | -$28.11 | -$7.55 |
| Income tax expense | $0.04 | $0.26 | $0.14 | $0.2 |
| Interest expense | -$15.84 | |||
| Net income | ||||
| Net income | -$9.47 | -$10.07 | -$12.41 | -$7.76 |
| Income (for common shares) | -$9.47 | -$10.07 | -$12.41 | -$7.76 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $122.37 | $105.52 | $110.56 | $86.38 |
| Cost of revenue | $51.72 | $58.72 | $48.83 | $38.2 |
| Gross Profit | $70.65 | $46.81 | $61.73 | $48.18 |
| Operating activities | ||||
| Research & development | $24.86 | $25.89 | $27.98 | $20.17 |
| Selling, general & administrative | $90.24 | $92 | $92.34 | $59.59 |
| Total operating expenses | $120.35 | $148.51 | $120.31 | $79.77 |
| Operating income | -$49.7 | -$101.7 | -$58.59 | -$31.58 |
| Income from continuing operations | ||||
| EBIT | -$47.45 | -$101.77 | -$57.32 | -$31.63 |
| Income tax expense | $0.72 | $0.07 | -$0.04 | -$0.38 |
| Interest expense | -$15.84 | -$5.13 | $0.4 | $0.27 |
| Net income | ||||
| Net income | -$32.33 | -$96.7 | -$57.69 | -$31.53 |
| Income (for common shares) | -$32.33 | -$96.7 | -$57.69 | -$31.53 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$9.47 | -$10.07 | -$12.41 | -$7.76 |
| Operating activities | ||||
| Depreciation | $1.96 | $2 | $2.07 | $2.46 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.23 | $5.26 | $4.33 | $4.34 |
| Total cash flows from operations | -$4.95 | -$20.16 | -$5.98 | -$4.05 |
| Investing activities | ||||
| Capital expenditures | -$1.6 | -$0.51 | -$2.22 | -$0.79 |
| Investments | $8.57 | -$108.69 | -$19.41 | -$125.2 |
| Total cash flows from investing | $6.97 | -$109.19 | -$21.63 | -$125.99 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.38 | $2.04 | $0.26 | $1.85 |
| Net borrowings | ||||
| Total cash flows from financing | -$0.33 | $0.6 | $0.2 | $1.8 |
| Effect of exchange rate | $0.03 | -$0.38 | $0.53 | -$0.07 |
| Change in cash and equivalents | $1.7 | -$128.76 | -$27.41 | -$128.24 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$32.33 | -$96.7 | -$57.69 | -$31.53 |
| Operating activities | ||||
| Depreciation | $8.38 | $6.06 | $5.35 | $4.56 |
| Business acquisitions & disposals | $0.52 | $7.28 | $3.3 | |
| Stock-based compensation | $16.76 | $15.44 | $15.97 | $10.1 |
| Total cash flows from operations | -$18.9 | -$48.27 | -$47.91 | -$23.36 |
| Investing activities | ||||
| Capital expenditures | -$3.79 | -$11.73 | -$13.62 | -$3.93 |
| Investments | -$144.61 | |||
| Total cash flows from investing | -$148.4 | -$11.21 | -$6.34 | -$0.63 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.89 | $2.31 | $278.53 | $96.31 |
| Net borrowings | -$7.74 | -$0.07 | ||
| Total cash flows from financing | $2.69 | $2.31 | $270.8 | $96.24 |
| Effect of exchange rate | $0.3 | -$0.54 | -$0.09 | $0.16 |
| Change in cash and equivalents | -$164.61 | -$57.17 | $216.55 | $72.25 |
News
Fundamentals
| Market cap | $476.90M |
|---|---|
| Enterprise value | $466.87M |
| Shares outstanding | 38.40M |
| Revenue | $129.33M |
|---|---|
| EBITDA | -$46.41M |
| EBIT | -$54.91M |
| Net Income | -$39.71M |
| Revenue Q/Q | 10.80% |
| Revenue Y/Y | 15.52% |
| P/E ratio | -12.01 |
|---|---|
| EV/Sales | 3.61 |
| EV/EBITDA | -10.06 |
| EV/EBIT | -8.50 |
| P/S ratio | 3.69 |
| P/B ratio | 1.40 |
| Book/Share | 8.85 |
| Cash/Share | 1.29 |
| EPS | -$1.03 |
|---|---|
| ROA | -9.47% |
| ROE | -11.52% |
| Debt/Equity | 0.23 |
|---|---|
| Net debt/EBITDA | -0.54 |
| Current ratio | 9.74 |
| Quick ratio | 8.99 |